Emory University’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-9,506
| Closed | -$645K | – | 19 |
|
|
2019
Q3 | $645K | Sell |
9,506
-33,460
| -78% | -$2.3M | 1.27% | 15 |
|
|
2019
Q2 | $2.5M | Buy |
42,966
+14,347
| +50% | +$850K | 1.76% | 12 |
|
|
2019
Q1 | $2M | Sell |
28,619
-1,700
| -6% | -$126K | 1.41% | 33 |
|
|
2018
Q4 | $1.95M | Sell |
30,319
-17,484
| -37% | -$1.23M | 1.54% | 24 |
|
|
2018
Q3 | $3.36M | Sell |
47,803
-22,667
| -32% | -$1.33M | 2.2% | 5 |
|
|
2018
Q2 | $3.55M | Sell |
70,470
-9,121
| -11% | -$362K | 2.36% | 4 |
|
|
2018
Q1 | $2.49M | Buy |
79,591
+16,665
| +26% | +$553K | 1.78% | 22 |
|
|
2017
Q4 | $2.15M | Buy |
62,926
+9,487
| +18% | +$302K | 1.85% | 6 |
|
|
2017
Q3 | $1.72M | Buy |
53,439
+980
| +2% | +$30.9K | 1.36% | 30 |
|
|
2017
Q2 | $1.71M | Sell |
52,459
-24,392
| -32% | -$773K | 1.51% | 15 |
|
|
2017
Q1 | $2.42M | Buy |
76,851
+12,704
| +20% | +$376K | 2.28% | 5 |
|
|
2016
Q4 | $1.89M | Buy |
+64,147
| New | +$1.96M | 1.86% | 14 |
|
|
2015
Q3 | $1.29M | Buy |
60,828
+5,862
| +11% | +$151K | 3.58% | 14 |
|
|
2015
Q2 | $1.53M | Buy |
54,966
+22,799
| +71% | +$643K | 2.07% | 10 |
|
|
2015
Q1 | $983K | Buy |
+32,167
| New | +$1.02M | 1.86% | 7 |
|
Emory University's GHDX Position: Q4 2019 in Review
Emory University sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 9,506 shares — an estimated $645K sold.
Emory University first reported a position in GHDX in Q1 2015 and held it in 15 quarters. The position peaked at $3.55M in Q2 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Emory University reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Emory University sold 9,506 Genomic Health, Inc. shares in Q4 2019, an estimated $645K.
- Emory University first reported a position in Genomic Health, Inc. in Q1 2015 and held it in 15 quarters.
- Emory University's Genomic Health, Inc. position peaked at $3.55M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Emory University's 13F filing for Q4 2019, filed 13 Feb 2020.